Invitation to upcoming Podcast Discussion

/

Rare Genomics Institute and RareShare are proud to invite you for the upcoming podcast discussing:

Living with Large Granulocyte Lymphocyte Leukemia (LGLL)-A Clinical & Research Perspective-Series II
DATE: 11/24/2015
TIME: 4:00 PM-5:00 PM EST (1:00 PM PST-9:00 PM GMT)

(Podcast Dial in Phone # 1-302-202-1112, Enter Podcast Dial in Code # 122681)


Are you interested in learning about recent clinical and research developments and available treatment options for LGLL?

What questions would you ask about symptom management of LGLL if you had the experts at hand?

Do you have any burning questions you have wanted to ask about LGLL but haven’t had the chance to?

Here is that chance!

The first 25 minute segment will feature medical scientists/clinicians discussing the latest developments in LGLL regarding genomics and biotechnology research, while the remaining 20 minutes will feature guest speakers will answer your questions/concerns/issues.

Here is your another  chance to ask any question you may have about Large Granulocyte Lymphocyte Leukemia
Submit your question(s) NOW with this form (RareShare LGLL Podcast Registration form) and/or register to attend the program.

An example question might be:
  What are the acute symptoms of LGLL?
  What can I expect for my spleen and B-Symptoms because I have LGLL? Or,
  What kinds of treatments are available to manage my Rheumtoid Arthritis and Neutropenia due to LGLL?

PS. If you cannot participate but would like to ask our experts any questions, please submit them below. The transcript and recording will be posted here on the RG Blog and also on the RareShare LGLL Community after the live Q&A.

Register here to reserve your spot in the call!

MODERATOR: Jimmy Lin
MD/PhD/MHS, President of RGI
  
Meet our Panel of Experts

Dr. Thomas P. Loughran, Jr, MD

Director of the University of Virginia Cancer Center, F. Palmer Weber-Smithfield Foods Professor of Oncology Research and Professor of Medicine

From July 2003 to August 2013, he served as the founding director of the Penn State Hershey Cancer Institute and Professor of Medicine at the Penn State College of Medicine. He previously served as program leader of hematologic malignancies at the H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, associate director of the Bone Marrow Transplant Program at SUNY Health Science Center, and chief of hematology at the Syracuse Veteran's Affairs Medical Center in Syracuse, N.Y. He completed his fellowship in medical oncology at the Fred Hutchinson Cancer Research Center under direction of Nobel Laureate, Dr. E.D. Thomas and remained on faculty there for seven years. Dr Loughran attended Hahnemann Medical School for his MD
 
Research Description
Dr. Loughran’s career as a physician-scientist has been a testament to translational research, with clinical observations leading to discoveries in the laboratory, and laboratory research contributing to improved clinical treatments. He was instrumental in the discovery of large granular lymphocyte (LGL) leukemia (Ann Intern Med 102:169, 1985), and is considered the worldwide expert in this disease. He has published numerous articles in high impact peer-reviewed journals including The New England Journal of Medicine, Annals of Internal Medicine, Lancet, Journal of Clinical Investigation, Journal of Clinical Oncology, and Blood.

His current research includes:

  • an R01 grant from the NIH’s National Cancer Institute to identify and characterize the LGL leukemia virus and understand how it might cause leukemia;
  • an NCI RO1 grant to study the pathogenesis of LGL leukemia;
  • a translational research grant from the Leukemia & Lymphoma Society to investigate new treatments for LGL leukemia;
  • a program project grant from the NCI aimed at developing new therapeutics for acute myelogenous leukemia

 

Dr. Lubomir Sokol, MD, PhD
Moffitt Cancer Center, Tampa, Florida

Dr Lubomir Sokol is a hematologist in, Tampa, Florida and is affiliated with Moffitt Cancer Center and specializes in Malignant Hematology, ET, Chemical Biology and Molecular Medicine Program and Center for Infection Research in Cancer. He received his medical degree from University Karlovy, Lek Fak Ii, Czech Republic and has been in practice for 34 years with the residency completed in Internal Medicine, Medical Oncology and Hematology at Louisiana State University and University of South Florida. His research included miRNA microarray profiling of MDS Molecular pathogenesis of Large granular lymphocyte leukemia Molecular pathogenesis of polycythemias. He has published his articles in various prestigious journal such as Blood Cancer, Oncotarget, BMC Cancer, Cancer Control, Journal of hematology and oncology and many more. 

Sign-in here to reserve your spot for the Podcast!